Filing Flows › Comparisons › CRL vs MEDP
Charles River Laboratories International vs Medpace Holdings: CRL and MEDP compared
Charles River Laboratories International is the larger company: $983M of revenue in its latest quarter (Q3 2026) against $716M for Medpace Holdings (Q3 2026). Medpace Holdings is growing faster (+8% against -2% a year earlier). Medpace Holdings is more profitable, with an operating margin of 23.1% against 20.6%.
Where the money goes: CRL and MEDP
Charles River Laboratories International (CRL) · Q3 2026
Charles River Laboratories International, Q3 2026: revenue $983M (-2% year over year), operating margin 20.6%, net earnings $333M, operating cash flow $254M. The chart follows the revenue to costs, profit and cash.
Medpace Holdings (MEDP) · Q3 2026
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
| Charles River Laboratories International (CRL) | Medpace Holdings (MEDP) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $983M | $716M |
| Revenue growth, Y/Y | -2% | +8% |
| Operating margin | 20.6% | 23.1% |
| Net earnings | $333M | $137M |
| Net margin | 33.9% | 19.2% |
| Operating cash flow | $254M | $217M |
| Free cash flow | $207M | $196M |
| Market value | $16.4B | $18.5B |
| P/E | — | 36.2× |
| Analysts’ mean target | $333.53 | $651.31 |
Where the revenue comes from
Charles River Laboratories International
- DSA: $596M (61%)
- RMS: $208M (21%)
- Manufacturing: $179M (18%)
Medpace Holdings
- Metabolic: $230M (32%)
- Other: $209M (29%)
- Oncology: $100M (14%)
- Cardiology: $83.6M (12%)
Questions
Which is bigger, Charles River Laboratories International or Medpace Holdings?
Charles River Laboratories International is the larger company: $983M of revenue in its latest quarter (Q3 2026) against $716M for Medpace Holdings (Q3 2026).
Is Charles River Laboratories International or Medpace Holdings growing faster?
Medpace Holdings is growing faster (+8% against -2% a year earlier).
Which is more profitable, Charles River Laboratories International or Medpace Holdings?
Medpace Holdings is more profitable, with an operating margin of 23.1% against 20.6%.
More: Charles River Laboratories International earnings · how Charles River Laboratories International makes money · Medpace Holdings earnings · how Medpace Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 22, 2026). Fiscal quarters can end on different dates. Not investment advice.